Journal
MOLECULAR NEUROBIOLOGY
Volume -, Issue -, Pages -Publisher
SPRINGER
DOI: 10.1007/s12035-021-02381-2
Keywords
PACAP; Sirt3; BDNF; Cognitive impairment; Apoptosis; Vascular dementia
Categories
Funding
- Beijing Municipal Science & Technology Commission [Z181100001518005]
- Strategic Priority Research Program of the Chinese Academy of Sciences [XDB39000000]
Ask authors/readers for more resources
The study demonstrates that PACAP regulates synaptic plasticity and exerts an anti-apoptotic role through Sirt3.
Background Pituitary adenylate cyclase-activating polypeptide (PACAP) has beneficial effects in learning and memory. However, the mechanism by which PACAP improves cognitive impairment of vascular dementia (VaD) is not clear. Methods We established a VaD model by bilateral common carotid stenosis (BCAS) to investigate the molecular mechanism of cognitive impairment. Protein levels of PACAP, Sirtuin 3 (Sirt3), brain-derived neurotrophic factor (BDNF), and postsynaptic density 95 (PSD-95) were assessed by Western blot. In vitro, oxygen glucose deprivation (OGD) was used to simulate the ischemia/hypoxia state. HT22 cells were transfected with Sirt3 knockdown and overexpression to study the relationship between PACAP, Sirt3, and BDNF. In vivo, PACAP was administered intranasally to assess its protective effects on BCAS. Results The study showed that the levels of PACAP, Sirt3, BDNF, and PSD-95 were decreased in the BCAS model of VaD. PACAP increased the protein levels of Sirt3, BDNF, PSD-95, Bcl-2, and Bax under OGD condition in vitro. Sirt3 regulated BDNF and synaptic plasticity. Intranasal PACAP increased the protein levels of PAC1, Sirt3, BDNF, and PSD-95 in vivo. Conclusions This study provides evidence that PACAP regulates synaptic plasticity and plays an antiapoptotic role through Sirt3.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available